Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer's disease and cerebral small vessel disease is a research paper published in Alzheimer s & Dementia (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01 AG024904
U.S. Department of Defense
Grant: W81XWH‐12‐2‐0012
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
Chongqing Natural Science Fund Key Project
Grant: cstc2019jcyj-zdxmX0029
Department of Defense
Grant: W81XWH-12-2-0012
Chongqing Natural Science Fund General Program
Grant: CSTB2023NSCQ-MSX0198
GE Healthcare
Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University
AbbVie
Transition Therapeutics
Cogstate
Eisai Inc.
EuroImmun
Biogen
Alzheimer's Disease Neuroimaging Initiative
Alzheimer's Drug Discovery Foundation
Servier
Lumosity
Bristol-Myers Squibb Company
Piramal Imaging
Takeda Pharmaceutical Company
Alzheimer's Association
Genentech, Inc.
Araclon Biotech
Meso Scale Diagnostics, LLC
Novartis Pharmaceuticals Corporation
CereSpir, Inc.
BioClinica, Inc.
NIBIB NIH HHS
Johnson & Johnson Pharmaceutical Research & Development LLC
Pfizer Inc.
Elan Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
IXICO Ltd.
NeuroRx Research
Merck & Co., Inc.
Janssen Alzheimer Immunotherapy Research & Development, LLC
Neurotrack Technologies
Fujirebio
Lundbeck
FWCI
2.83
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals